ASX - By Stock
|
BOD |
Re:
Ann: Delay in lodgement of Appendix 4D and Half Year Report
|
|
dc3
|
5 |
1.9K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
5
|
1.9K
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dc3
|
5 |
1.7K |
0 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
5
|
1.7K
|
0
|
|
ASX - By Stock
|
WOA |
Re:
Ann: WOA partners with Nissei for Buntine Protein distribution
|
|
dc3
|
13 |
4.5K |
1 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
13
|
4.5K
|
1
|
|
ASX - By Stock
|
WOA |
Re:
Ann: Letter from CEO providing business update
|
|
dc3
|
28 |
10K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
WOA |
Re:
Ann: Letter from CEO providing business update
|
|
dc3
|
28 |
10K |
4 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
28
|
10K
|
4
|
|
ASX - By Stock
|
WOA |
Re:
Ann: Share Purchase Plan Reminder
|
|
dc3
|
7 |
2.2K |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
7
|
2.2K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Extension of Convening Period for 2nd Meeting of Creditors
|
|
dc3
|
6 |
3.0K |
0 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
6
|
3.0K
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Medicinal cannabis supply agreement with Green Farmers
|
|
dc3
|
10 |
3.8K |
3 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
10
|
3.8K
|
3
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Appointment of Voluntary Administrators
|
|
dc3
|
36 |
14K |
2 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
36
|
14K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Notice to Shareholders
|
|
dc3
|
7 |
1.8K |
3 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
7
|
1.8K
|
3
|
|
ASX - By Stock
|
WOA |
Re:
News: WOA Wide Open Agriculture Says Unit Signs A Non-Binding Term Sheet
|
|
dc3
|
19 |
6.3K |
12 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
19
|
6.3K
|
12
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Bod Science announces placement to raise A$2m
|
|
dc3
|
55 |
11K |
1 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
55
|
11K
|
1
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Bod Science announces placement to raise A$2m
|
|
dc3
|
55 |
11K |
2 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
55
|
11K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Bod Science announces placement to raise A$2m
|
|
dc3
|
55 |
11K |
2 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
55
|
11K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Bod Science announces placement to raise A$2m
|
|
dc3
|
55 |
11K |
5 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
55
|
11K
|
5
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Grant of ASX waiver regarding Aqua Phase acquisition
|
|
dc3
|
4 |
1.1K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
4
|
1.1K
|
2
|
|
ASX - By Stock
|
WOA |
Re:
[INTERVIEW] Wide Open Agriculture to become world’s largest lupin protein producer
|
|
dc3
|
12 |
5.2K |
6 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
12
|
5.2K
|
6
|
|
ASX - By Stock
|
WOA |
Re:
[INTERVIEW] Wide Open Agriculture to become world’s largest lupin protein producer
|
|
dc3
|
12 |
5.2K |
5 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
12
|
5.2K
|
5
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Schedule 3 CBD trial preliminary results
|
|
dc3
|
26 |
7.2K |
1 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
26
|
7.2K
|
1
|
|
ASX - By Stock
|
WOA |
Re:
Ann: Clarification of Announcement of 19 April 2023
|
|
dc3
|
14 |
4.8K |
1 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
14
|
4.8K
|
1
|
|
ASX - By Stock
|
WOA |
Re:
Ann: Clarification of Announcement of 19 April 2023
|
|
dc3
|
14 |
4.8K |
1 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
14
|
4.8K
|
1
|
|
ASX - By Stock
|
WOA |
Re:
Ann: Clarification of Announcement of 19 April 2023
|
|
dc3
|
14 |
4.8K |
6 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
14
|
4.8K
|
6
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Date of AGM
|
|
dc3
|
5 |
816 |
0 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
5
|
816
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Date of AGM
|
|
dc3
|
5 |
816 |
0 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
5
|
816
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Schedule 3 CBD trial preliminary results
|
|
dc3
|
26 |
7.2K |
2 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
26
|
7.2K
|
2
|
|
ASX - By Stock
|
NXT |
Re:
Ann: Change of Director's Interest Notice
|
|
dc3
|
2 |
1.3K |
8 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
2
|
1.3K
|
8
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Bod completes acquisition of Aqua Phase
|
|
dc3
|
22 |
4.8K |
10 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
22
|
4.8K
|
10
|
|
ASX - By Stock
|
EMD |
Re:
Ann: June 2023 Quarterly Activities Report and Appendix 4C
|
|
dc3
|
17 |
5.7K |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
17
|
5.7K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: June 2023 Quarterly Activities Report and Appendix 4C
|
|
dc3
|
17 |
5.7K |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
17
|
5.7K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: June 2023 Quarterly Activities Report and Appendix 4C
|
|
dc3
|
17 |
5.7K |
5 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
17
|
5.7K
|
5
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Completion of Pivotal Aqua Phase PK Studies
|
|
dc3
|
13 |
4.3K |
7 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
13
|
4.3K
|
7
|
|
ASX - By Stock
|
QFE |
Re:
Ann: Q4 FY23 business update
|
|
dc3
|
13 |
6.6K |
5 |
23/07/23 |
23/07/23 |
ASX - By Stock
|
13
|
6.6K
|
5
|
|
ASX - By Stock
|
QFE |
Re:
Ann: Q4 FY23 business update
|
|
dc3
|
13 |
6.6K |
5 |
22/07/23 |
22/07/23 |
ASX - By Stock
|
13
|
6.6K
|
5
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Phase IIB Clinical Trial of Schedule 3
|
|
dc3
|
17 |
4.0K |
2 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
17
|
4.0K
|
2
|
|
ASX - By Stock
|
AMX |
Re:
Undervalued / Under radar tech stock
|
|
dc3
|
148 |
92K |
1 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
148
|
92K
|
1
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Updates regarding Aqua Phase Delivery Technology
|
|
dc3
|
14 |
3.7K |
3 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
14
|
3.7K
|
3
|
|
ASX - By Stock
|
BOD |
S3 First Mover Advantage
|
|
dc3
|
4 |
1.1K |
0 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
DDR |
Re:
Ann: Acquisition of Hills Security and IT Division
|
|
dc3
|
7 |
3.3K |
12 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
7
|
3.3K
|
12
|
|
ASX - By Stock
|
AMX |
Re:
Ann: AMX appoints Steven Masters as Managing Director and CEO
|
|
dc3
|
18 |
7.7K |
1 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
18
|
7.7K
|
1
|
|
ASX - By Stock
|
AMX |
Re:
Metaverce
|
|
dc3
|
34 |
15K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
34
|
15K
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: BOD to conduct Schedule 3 clinical trial of new CBD product
|
|
dc3
|
13 |
3.6K |
0 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
13
|
3.6K
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ann: BOD to conduct Schedule 3 clinical trial of new CBD product
|
|
dc3
|
13 |
3.6K |
3 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
13
|
3.6K
|
3
|
|
ASX - By Stock
|
AMX |
Re:
Ann: Aerometrex signs US 3D sale in emerging Metaverse market
|
|
dc3
|
11 |
5.6K |
12 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
11
|
5.6K
|
12
|
|
ASX - By Stock
|
WOA |
Re:
News and media
|
|
dc3
|
488 |
186K |
12 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
488
|
186K
|
12
|
|
ASX - By Stock
|
BOD |
Re:
Ann: BOD to conduct Schedule 3 clinical trial of new CBD product
|
|
dc3
|
13 |
3.6K |
0 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
13
|
3.6K
|
0
|
|
ASX - By Stock
|
DDR |
Re:
Ann: Change of Director's Interest Notice - VM
|
|
dc3
|
2 |
1.6K |
1 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
2
|
1.6K
|
1
|
|
ASX - By Stock
|
DDR |
Re:
Short Attack - Price Manipulation
|
|
dc3
|
312 |
125K |
0 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
312
|
125K
|
0
|
|
ASX - By Stock
|
DDR |
Re:
Ann: Sale of Shares by David Dicker
|
|
dc3
|
30 |
11K |
2 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
30
|
11K
|
2
|
|
ASX - By Stock
|
DDR |
Re:
Ann: Sale of Shares by David Dicker
|
|
dc3
|
30 |
11K |
3 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
30
|
11K
|
3
|
|
ASX - By Stock
|
AMX |
Re:
Undervalued / Under radar tech stock
|
|
dc3
|
148 |
92K |
13 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
148
|
92K
|
13
|
|